Nizhpharm

Nizhpharm is a leading Russian pharmaceutical company and a cornerstone of the STADA Group's operations in the CIS region. Founded in 1919 and headquartered in Nizhny Novgorod, the company specializes in the development, manufacturing, and marketing of high-quality generic and value-added medicines. Its extensive product portfolio is particularly strong in topical dosage forms, including ointments, gels, and suppositories, covering therapeutic areas such as dermatology, gynecology, urology, and pain management. Nizhpharm operates state-of-the-art manufacturing facilities that are fully compliant with international Good Manufacturing Practice (GMP) standards. Since its acquisition by STADA in 2004, the company has integrated into a global supply network, exporting products to numerous countries while maintaining a dominant position in the Russian domestic market.